Tanuxiciclib
Product Specifications
UNSPSC Description
Tanuxiciclib is a cyclin dependent kinase (CDK) inhibitor[1].
Target Antigen
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tanuxiciclib.html
Solubility
DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
FC1=C(C2=CC=C(O)C(C3=CC(C)=NC(N)=N3)=N2)C=CN=C1N
Molecular Weight
312.30
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 35, No. 4, 2021.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-145599/Tanuxiciclib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-145599/Tanuxiciclib-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1983983-64-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1149310-01 0.05 mg (E-Coli)
Recombinant Nectria haematococca Fe-S cluster assembly protein DRE2 (DRE2)
Ask
View Details MBS1149310-02 0.05 mg (Yeast)
Recombinant Nectria haematococca Fe-S cluster assembly protein DRE2 (DRE2)
Ask
View Details 
MBS1149310-03 0.2 mg (E-Coli)
Recombinant Nectria haematococca Fe-S cluster assembly protein DRE2 (DRE2)
Ask
View Details MBS1149310-04 0.05 mg (Baculovirus)
Recombinant Nectria haematococca Fe-S cluster assembly protein DRE2 (DRE2)
Ask
View Details MBS1149310-05 0.5 mg (E-Coli)
Recombinant Nectria haematococca Fe-S cluster assembly protein DRE2 (DRE2)
Ask
View Details